PCOS is Now PMOS: The Good, The Bad, The Transition

Polycystic ovary syndrome (PCOS) got a major rebrand in May 2026, and it has taken the internet by storm. In this solo episode of Phase to Phase: The Hormone Health Show, Dr. Anne Hussain breaks down the shift from PCOS to PMOS: Polyendocrine Metabolic Ovarian Syndrome. She unpacks the science behind the new 15-syllable acronym (in plain language), why the polycystic ovary label was a misnomer and recently dropped, and how this updated terminology better reflects the multisystem, whole-body nature of the condition, especially the multiple hormones and insulin resistance involved. Dr. Anne covers what this means for your current diagnosis, whether your treatment plan will actually change, and what to expect as international guidelines get an update in 2028. She also tackles the downsides and criticisms of rebranding a condition affecting millions of people across the world. Finally, she leaves you with the most important reminder that the most important parts of the conversation, whether it’s called PCOS or PMOS, are you and your wellbeing.
Key Takeaways

What does PMOS stand for? PMOS stands for Polyendocrine Metabolic Ovarian Syndrome. It is the new, official medical term for what was previously known as Polycystic Ovary Syndrome (PCOS), reflecting the true multisystem nature of the condition.
Why was the name changed from PCOS to PMOS? The term "polycystic" is misleading, reductive, and incomplete. Patients do not actually develop ovarian cysts; they develop arrested egg follicles due to altered folliculogenesis which we know as polycystic ovarian morphology. The new name acknowledges that PMOS is a full-body disorder involving widespread hormonal dysregulation (like testosterone, DHEA, GnRH), metabolic dysfunction (like insulin resistance and increased cardiometabolic risk), and ovarian dysfunction (like missing periods, anovulatory menstrual cycles).
Do I have to get re-diagnosed if I already have PCOS? Nope. PMOS is an updated name for the exact same condition. Patients already diagnosed with PCOS automatically fall under the PMOS terminology without needing new testing or a separate diagnosis.
Does the PMOS diagnosis change my treatment plan? At its core, and especially imminently, no. Our fundamental understanding of the condition hasn’t changed. However, by putting "metabolic" and "polyendocrine" right in the name, it pushes the medical community to treat root hormonal and metabolic drivers rather than just treating isolated reproductive symptoms like irregular periods, so hopefully you’ll get better care!
What are the main criticisms of the PMOS name change? While scientifically accurate, a new name doesn't fix a broken healthcare system. Criticisms include the disruption of patient-led advocacy networks due to sudden SEO and algorithmic shifts, the exclusion of people without ovaries by keeping "ovarian" in the name, and the risk of corporations and grifters profiteering off the new "metabolic" label. Ultimately, your access to care is still heavily dictated by systemic policies, your postal code, and other factors.
What is the timeline for the PMOS transition? According to the official rollout strategy published in The Lancet, there is a managed 3-year transition plan. This includes updating Electronic Health Records, engaging with the World Health Organization for new diagnostic codes, and fully integrating the PMOS framework into the International Guidelines by 2028.